Literature DB >> 7382423

Aspirin treatment and platelet function in Kawasaki disease.

T Yokoyama, H Kato, E Ichinose.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7382423     DOI： 10.2739/kurumemedj.27.57

Source DB:  PubMed          Journal:  Kurume Med J        ISSN： 0023-5679


× No keyword cloud information.
  6 in total

Review 1.  Pharmacological therapy for patients with Kawasaki disease.

Authors:  R V Williams; L L Minich; L Y Tani
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  Salicylate treatment in Kawasaki disease: high dose or low dose?

Authors:  T Akagi; H Kato; O Inoue; N Sato
Journal:  Eur J Pediatr       Date:  1991-07       Impact factor: 3.183

Review 3.  Probable role of Streptococcus pyogenes in Kawasaki disease.

Authors:  T Akiyama; K Yashiro
Journal:  Eur J Pediatr       Date:  1993-02       Impact factor: 3.183

4.  Monocyte platelet aggregates in children with Kawasaki disease- a preliminary study from a tertiary care centre in North-West India.

Authors:  Pandiarajan Vignesh; Amit Rawat; Jitendra Kumar Shandilya; Man Updesh Singh Sachdeva; Jasmina Ahluwalia; Surjit Singh
Journal:  Pediatr Rheumatol Online J       Date:  2021-03-12       Impact factor: 3.054

5.  Is high-dose aspirin necessary in the acute phase of kawasaki disease?

Authors:  Goni Lee; Seung Eun Lee; Young Mi Hong; Sejung Sohn
Journal:  Korean Circ J       Date:  2013-03-31       Impact factor: 3.243

6.  Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease.

Authors:  Karl Migally; Elizabeth A Braunlin; Lei Zhang; Bryce A Binstadt
Journal:  Pediatr Res       Date:  2018-05-02       Impact factor: 3.756
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.